<%@ Page Language="C#" %>

<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">

<script runat="server">

</script>

<html xmlns="http://www.w3.org/1999/xhtml">
<head runat="server">
    <title>Untitled Page</title>
    <style type="text/css">

        .style1
        {
            width: 100%;
            height: 521px;
        }
        .style7
        {
            height: 45px;
        }
        .style8
        {
            height: 45px;
        }
        .style3
        {
            width: 224px;
            height: 128px;
        }
        .style4
        {
            height: 128px;
        }
        .style2
        {
            width: 224px;
        }
        .style5
        {
            width: 224px;
            height: 144px;
        }
        .style6
        {
            height: 144px;
        }
        .style9
        {
            height: 45px;
            font-weight: bold;
            font-style: italic;
            font-size: xx-large;
            color: #99CCFF;
        }
    </style>
</head>
<body>
    <form id="form1" runat="server">
    <div>
    
        <table border="2" class="style1">
            <tr>
                <td class="style9" colspan="2">
                    Acid phosphatase - plasma or serum</td>
            </tr>
            <tr>
                <td class="style7">
                    Last updated</td>
                <td class="style8">
                    Friday, 02, April, 2004</td>
            </tr>
            <tr>
                <td class="style3">
                    Specimen:                 </td>
                <td class="style4">
                    5 mL blood in lithium heparin or plain tube. May require early separation into 
                    tube with special preservatives. Defer collection for at least 72 hours after 
                    rectal examination, urethral instrumentation, prostatic massage or FNAB, as high 
                    levels may result from these procedures.</td>
            </tr>
            <tr>
                <td class="style2">
                    Method:</td>
                <td>
                    Immunoassay, spectrophotometry.</td>
            </tr>
            <tr>
                <td class="style2">
                    Reference Interval:</td>
                <td>
                    Method dependent - consult pathologist.</td>
            </tr>
            <tr>
                <td class="style2">
                    Application :</td>
                <td>
                    Test largely superseded by prostate specific antigen assay, which has greater 
                    sensitivity and specificity for the detection of invasive or metastatic 
                    adenocarcinoma of the prostate.<br />
                    May be useful in monitoring Gaucher disease.</td>
            </tr>
            <tr>
                <td class="style5">
                    Interpretation:</td>
                <td class="style6">
                    The test is relatively specific for the prostatic isoenzyme. High levels 
                    indicate tumour extension beyond the prostatic capsule or metastatic spread. A 
                    normal level does not exclude the diagnosis of prostatic malignancy. The 
                    preferred test is Prostate specific antigen.</td>
            </tr>
            <tr>
                <td class="style2">
                    Reference:
                </td>
                <td>
                    Gao X et al. Diagnostic and prognostic markers for human prostate cancer. 
                    (Review.) Prostate 1997; 31: 264-81.</td>
            </tr>
        </table>
    
    </div>
    </form>
</body>
</html>
